ACTG A5324 is a phase IV randomized, double-blinded, placebo-controlled study to assess the efficacy of adding Maraviroc (MVC)...
This study is being done in people who are starting HIV treatment and who live in areas where the TB infection rate is high. The...
The study is being done to: test a strategy of using a resistance test to choose anti-HIV drugs. Resistance tests look at the...
IMPAACT 2010 is a Phase III, three-arm, randomized, open-label study of HIV-1-infected pregnant women initiating either a...
Objectives: Primary: To develop a highly predictive algorithm that identifies TB patients who will be cured by treatment...
